Humoral and cellular immunity to varicella-zoster virus: an overview.
about
Systems vaccinology: probing humanity's diverse immune systems with vaccines.Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans.Disseminated cutaneous herpes zoster in an immunocompetent elderly patientPresentation and management of herpes zoster (shingles) in the geriatric population.Herpes zoster: diagnostic, therapeutic, and preventive approaches.Systems vaccinology.Immune aging and autoimmunity.Immunological mechanisms of vaccination.Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age.Varicella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation.Genome-wide analysis of T cell responses during acute and latent simian varicella virus infections in rhesus macaquesCytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.Natural and adoptive T-cell immunity against herpes family viruses after allogeneic hematopoietic stem cell transplantation.Complicated Varicella Infection at 8-year-old Boy with Pulmonary Agenesis.The herpes zoster subunit vaccine.Two cases of herpes zoster appearing after botulinum toxin type a injections.Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis.The Role of Childhood Infections and Immunizations on Childhood Rhabdomyosarcoma: A Report From the Children's Oncology Group.Herpes zoster - typical and atypical presentations.Vaccine profile of herpes zoster (HZ/su) subunit vaccine.T-lymphocyte Subsets as a Prognostic Factor in a Clinical Course of Chickenpox.A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus.Adjuvant system AS01: helping to overcome the challenges of modern vaccines.Varicella zoster virus (VZV) and herpes simplex virus (HSV) in solid organ transplant patients.Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.Varicella-zoster virus antigen expression of eccrine gland and duct epithelium in herpes zoster lesions.Varicella and herpes zoster vaccine development: lessons learned.Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009-2014.The development of autoimmune features in aging mice is closely associated with alterations of the peripheral CD4⁺ T-cell compartment.Development of cytomegalovirus and adenovirus-specific memory CD4 T-cell functions from birth to adulthood.Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged ≥50 Years.Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenic.Varicella-zoster virus meningitis with hypoglycorrhachia in a young immunocompetent adult without rash: A case report and literature review.Risk and impact of herpes zoster among COPD patients: a population-based study, 2009-2014.
P2860
Q27690799-DBACF73E-0461-4B05-AB9B-23597245DBC2Q30884283-D1C7AB17-857B-4EC7-ACA9-0EE64AA0CA9AQ34259163-F1169D7A-3DD8-482D-905A-A157E95DE679Q34352218-FD08F763-3FE8-44F4-98D3-C44320430E55Q34376752-351FC85E-418C-4B40-9351-7E0ABAC2525FQ34402910-5BD23E9D-8012-4D41-8776-A44582452F86Q34777989-BD67FB54-8809-4D51-867B-4986ED0A951EQ35659533-7C1689AE-C86D-41C8-B2CE-5EDEA361F73AQ35887597-EA675BBC-7E93-4F7F-B242-A2984021493EQ35889270-1CA1B881-AE8E-488E-9434-8C69384D76E7Q36006384-E38F47C5-8D75-4B2B-AC92-4F7B4BD3BE6CQ37252780-DDF7CA5C-FD8B-467A-B6C1-126D86843670Q37559627-EBCB22A0-ECF5-4AD0-915A-C5E479919C80Q37888687-1C6AB3D5-9F37-48F0-8E3E-74798A6920B9Q38185024-C1F00F61-FABE-4E8A-B867-585223331E3DQ38728931-2E722890-ADB3-4013-A3B1-C35FD53CB1F4Q38746829-08F24D2C-D028-4974-B06D-ACA04AD14E5DQ40046059-3004FB59-363B-4D36-9F9E-CAAF4A003899Q40104965-C7514054-CFDA-4D2C-852F-F4419E7A78E8Q40187065-2AB87539-6F3F-4776-952A-0A352D7584EAQ40208840-9D68B8E2-EE99-4AF0-8718-3FE0B24AE046Q40220736-B7F4128C-F0CE-46FF-B0DB-290ACCB76CE3Q40234780-E0C28F95-6240-487F-A9B8-1E5856BD957CQ42051427-B41ACB71-C853-4E8D-AD85-970EDA04730AQ42277082-23CB33C1-5AE9-4D19-9D17-A47EAD49086FQ45226113-47AA2E2A-7F96-488A-B39E-D0F47C14BDFDQ45365568-198679EA-A059-4E28-9935-D4F17388DA9BQ47607699-4E4F3894-2749-45E7-9F54-839D6FADFF7FQ49300391-5280B3E1-31FC-423C-9F16-3DE8D649CB3BQ50647528-60FAF28B-26FB-4ADB-8BB8-ABF8E9CE1591Q51031172-1232377F-1B4E-41C1-9EE4-1C54EBF811E6Q52727148-7794E6BB-331C-4C52-902E-A8BDB59D9DD4Q53144149-C1346779-35F1-4C7F-92B7-191BAA6F753BQ54091458-0929580D-EF38-4926-97BE-C1CE43F37A2DQ55004402-0CA9CBFE-240E-4CC7-9D73-662C6AC32871
P2860
Humoral and cellular immunity to varicella-zoster virus: an overview.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Humoral and cellular immunity to varicella-zoster virus: an overview.
@en
Humoral and cellular immunity to varicella-zoster virus: an overview.
@nl
type
label
Humoral and cellular immunity to varicella-zoster virus: an overview.
@en
Humoral and cellular immunity to varicella-zoster virus: an overview.
@nl
prefLabel
Humoral and cellular immunity to varicella-zoster virus: an overview.
@en
Humoral and cellular immunity to varicella-zoster virus: an overview.
@nl
P2860
P356
P1476
Humoral and cellular immunity to varicella-zoster virus: an overview.
@en
P2093
Ann M Arvin
P2860
P304
P356
10.1086/522123
P407
P478
197 Suppl 2
P577
2008-03-01T00:00:00Z